Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Open this folder and view contentsOpening ceremony
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Close this folderAntimicrobial resistance - new initiatives
View the documentWHO’s global strategy for the containment of antimicrobial resistance
View the documentImplementing a strategy for the containment of antimicrobial resistance: experience in Uganda
View the documentVeterinary issues contributing to antimicrobial resistance
View the documentStatus of regulation of antimicrobials in Cuba
View the documentFighting antibiotic resistance in Sweden
View the documentAntimicrobial use in Chile - the impact of regulatory measures
View the documentRecommendations
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Open this folder and view contentsHomoeopathy
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Implementing a strategy for the containment of antimicrobial resistance: experience in Uganda

Mr Gabriel K. Kaddu, Uganda

Drug-resistant pathogens are a growing menace to all people regardless of age, sex or socioeconomic background. Uganda is currently implementing a strategy for the containment of antimicrobial resistance, in line with the recommendations of the World Health Assembly. Several interventions have been undertaken:

Only antimicrobials that meet international standards of quality, safety and efficacy are granted marketing authorization. This is ensured by:

• inspecting manufacturing facilities before registering a product;

• inspecting drug consignments and assessing quality before releasing for distribution;

• making mandatory an analysis of all antimalarials, antituberculosis drugs, antibacterials and condoms before release for distribution.


The availability of antimicrobials is restricted by:

• protecting “drugs of last resort”;
• controlling and monitoring importation and distribution of antiretroviral drugs;
• importing rifampicin solely for the treatment of tuberculosis;
• ensuring in the registration system that packages contain the full dosages.


Standard treatment guidelines have been strengthened by:

• updating to include diagnostic guidelines;
• testing their impact.


Campaigns have been carried out using media and social marketing techniques to educate patients by:

• targeting immunization, vector control and bednets;
• emphasizing the importance of good hygiene in preventing transmission of infection;
• stressing the importance of total compliance with dosages.


Education has been provided to prescribers and dispensers (including drug sellers) through:

• support for continuing medical education programmes;
• training in rational drug use;
• encouraging training for staff with no formal medical training.


The accessibility of health care to the entire population of Uganda is ensured by:

• establishing public-private relationships;
• encouraging opening of rural pharmacies;
• recruiting medical staff for all subcounties;
• establishing health centres in all subcounties.


A vigorous fight is being conducted against counterfeit and substandard drugs.

Action is being taken against drug-hawking and the sale of medicines in open markets.

Drug needs, use and resistance patterns are being determined in each district.

There is a continuing need to work together to address the threat of antimicrobial resistance.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014